Provided by Tiger Trade Technology Pte. Ltd.

MediciNova

1.45
+0.00500.35%
Volume:5K
Turnover:7.75K
Market Cap:71.02M
PE:-6.60
High:1.46
Open:1.44
Low:1.44
Close:1.44
52wk High:1.96
52wk Low:1.17
Shares:49.15M
Float Shares:43.50M
Volume Ratio:0.32
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2188
EPS(LYR):-0.2445
ROE:-25.56%
ROA:-16.41%
PB:1.91
PE(LYR):-5.91

Loading ...

MediciNova Receives Notice of Allowance for New Patent Covering Use of MN-166 in Combination with Anti-PD-1 Immune Checkpoint Inhibitor for Glioblastoma Treatment

GlobeNewswire
·
Jun 08

Analysts’ Top Healthcare Picks: Coherus Biosciences (CHRS), Medicinova (MNOV)

TIPRANKS
·
May 29

Analyst Initiates Buy on MediciNova, Citing Pivotal Tipelukast and Ibudilast Catalysts to Support $10 Price Target

TIPRANKS
·
May 28

MediciNova completes Phase 2 trial last patient visit for MN-001 in NAFLD, hypertriglyceridemia linked to type 2 diabetes

Reuters
·
May 27

Medicinova Announces Completion of Last Patient Last Visit in the Mn-001-Natg-202 Clinical Trial of Mn-001 (Tipelukast)

THOMSON REUTERS
·
May 27

MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)

GlobeNewswire
·
May 27

MediciNova Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 15

MediciNova Inc expected to post a loss of 7 cents a share - Earnings Preview

Reuters
·
May 08

MediciNova Is Maintained at Buy by D. Boral Capital

Dow Jones
·
May 04

MediciNova’s peer-reviewed ibudilast study advances clinical translation

TIPRANKS
·
Apr 28

MediciNova plans clinical studies of ibudilast for brain metastases after CNIO findings

Reuters
·
Apr 28

New Peer‑Reviewed Study Reveals Actionable Immune–Microenvironment Target in Brain Metastasis; Medicinova Advances Clinical Translation

GlobeNewswire
·
Apr 28

MediciNova announces annual shareholder meeting

Reuters
·
Apr 18

MediciNova Price Target Announced at $6.00/Share by Maxim Group

Dow Jones
·
Mar 23

MediciNova resumed with a Buy at Maxim

TIPRANKS
·
Mar 23

MediciNova Initiated at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 16

MediciNova executives to meet investors at the 38th Annual ROTH Conference

Reuters
·
Mar 16

MediciNova to Participate at the 38th Annual ROTH Conference

GlobeNewswire
·
Mar 16

MediciNova initiated with a Buy at H.C. Wainwright

TIPRANKS
·
Mar 16

Medicinova, Inc. : H.c. Wainwright Initiates Coverage With Buy Rating

THOMSON REUTERS
·
Mar 16